108 related articles for article (PubMed ID: 21454186)
41. American Association for Cancer Research--97th annual meeting.
Kondo Y; Kondo S
IDrugs; 2006 Jun; 9(6):409-11. PubMed ID: 16752309
[No Abstract] [Full Text] [Related]
42. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
[TBL] [Abstract][Full Text] [Related]
43. VDAC upregulation and αTAT1‑mediated α‑tubulin acetylation contribute to tanespimycin‑induced apoptosis in Calu‑1 cells.
Wang Q; Liu X
Oncol Rep; 2020 Dec; 44(6):2725-2734. PubMed ID: 33125132
[TBL] [Abstract][Full Text] [Related]
44. A phase 1 study of IPI-504 (retaspimycin hydrochloride) in patients with relapsed or relapsed and refractory multiple myeloma.
Siegel D; Jagannath S; Vesole DH; Borello I; Mazumder A; Mitsiades C; Goddard J; Dunbar J; Normant E; Adams J; Grayzel D; Anderson KC; Richardson P
Leuk Lymphoma; 2011 Dec; 52(12):2308-15. PubMed ID: 21851215
[TBL] [Abstract][Full Text] [Related]
45. [Development of novel agents for multiple myeloma; now and the future].
Hata H
Rinsho Ketsueki; 2011 Aug; 52(8):603-8. PubMed ID: 21897065
[No Abstract] [Full Text] [Related]
46. Engineering of multifunctional temperature-sensitive liposomes for synergistic photothermal, photodynamic, and chemotherapeutic effects.
Tran TH; Nguyen HT; Le NV; Tran TTP; Lee JS; Ku SK; Choi HG; Yong CS; Kim JO
Int J Pharm; 2017 Aug; 528(1-2):692-704. PubMed ID: 28642202
[TBL] [Abstract][Full Text] [Related]
47. Novel agents in the treatment of pancreatic adenocarcinoma.
Dimou A; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):138-40. PubMed ID: 23474556
[TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment.
Lodi A; Ronen SM
PLoS One; 2011; 6(10):e26155. PubMed ID: 22022547
[TBL] [Abstract][Full Text] [Related]
49. Comment on "Lowpenetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras" by Park et al.
Harbour JW
Cell Cycle; 2008 Aug; 7(15):2276-7. PubMed ID: 18682685
[No Abstract] [Full Text] [Related]
50. JPMorgan 24th Annual Healthcare Conference.
Dalziel C
IDrugs; 2006 Mar; 9(3):182-4. PubMed ID: 16523382
[No Abstract] [Full Text] [Related]
51. American Society of Clinical Oncology--42nd annual meeting. 2-6 June 2006, Atlanta, GA, USA.
Chan D; Cleverley J; Searle B
IDrugs; 2006 Aug; 9(8):517-9. PubMed ID: 16871452
[No Abstract] [Full Text] [Related]
52. Redefining bioactive small molecules from microbial metabolites as revolutionary anticancer agents.
Giurini EF; Godla A; Gupta KH
Cancer Gene Ther; 2024 Feb; 31(2):187-206. PubMed ID: 38200347
[TBL] [Abstract][Full Text] [Related]
53. From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment.
Astrain-Redin N; Sanmartin C; Sharma AK; Plano D
J Med Chem; 2023 Mar; 66(6):3703-3731. PubMed ID: 36858050
[TBL] [Abstract][Full Text] [Related]
54. Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study.
Federico A; Fratello M; Scala G; Möbus L; Pavel A; Del Giudice G; Ceccarelli M; Costa V; Ciccodicola A; Fortino V; Serra A; Greco D
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454948
[TBL] [Abstract][Full Text] [Related]
55. Senotherapeutics in Cancer and HIV.
Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
[TBL] [Abstract][Full Text] [Related]
56. secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics.
Kumar H; Mazumder S; Chakravarti S; Sharma N; Mukherjee UK; Kumar S; Baughn LB; Van Ness BG; Mitra AK
Blood Cancer J; 2022 Mar; 12(3):39. PubMed ID: 35264575
[TBL] [Abstract][Full Text] [Related]
57. Exploration of Prognostic Immune-Related Genes and lncRNAs Biomarkers in Kidney Renal Clear Cell Carcinoma and Its Crosstalk with Acute Kidney Injury.
Juan C; Zhu Y; Zhou Y; Zhu W; Wang X; He W; Chen Y
J Oncol; 2022; 2022():6100187. PubMed ID: 35178091
[TBL] [Abstract][Full Text] [Related]
58. Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication.
Jiang N; Zhang X; Qin D; Yang J; Wu A; Wang L; Sun Y; Li H; Shen X; Lin J; Kantawong F; Wu J
Front Genet; 2021; 12():608017. PubMed ID: 33708237
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing's Disease.
Shen Y; Ji C; Jian X; Zhou J; Zhang Q; Qiao N; Zhang Y; Shou X; Zhou X; Ma Z
Front Endocrinol (Lausanne); 2020; 11():601984. PubMed ID: 33537004
[TBL] [Abstract][Full Text] [Related]
60. Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.
Yñigez-Gutierrez AE; Bachmann BO
J Med Chem; 2019 Sep; 62(18):8412-8428. PubMed ID: 31026161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
